Table 1.

36 MCRs of genomic gain and loss in 392 newly-diagnosed DLBCL specimens.

Genomic Gains			Genomic Losses
MCR CNA	Start (Mbp)	End (Mbp)	MCR CNA	Start (Mbp)	End (Mbp)
A1q22.1-q25.1	145,390,170	174,990,852	D1p36.32-36.31	2,436,018	6,342,694
A1q31.3-q32.1	196,256,151	206,325,234	D1p13.1	116,368,309	117,144,417
A2p16.1-p15	57,798,324	64,087,027	D2q22.3	144,608,496	146,483,034
A3q27.3-q29	187,651,865	196,853,350	D2q24.2	161,836,066	161,963,707
A5p15.33	304,462	1,944,706	D3p21.31-p21.2	48,849,803	50,713,840
A6p21.32-p21.2	32,192,560	37,798,373	D3p14.2	60,408,342	60,690,266
A7p22.2	2,804,495	3,921,089	D6p21.33	30,919,878	31,536,224
A8q24.3	144,439,451	146,138,827	D6q11.1-q27	61,962,715	170,373,079
A9q34.3	138,543,735	140,878,804	D8p22-21.3	13,241,832	23,112,533
A11p15.4	3,225,556	3,808,818	D9p24.1	4,971,499	5,596,997
A11q23.3	120,599,996	120,820,140	D9p21.3	21,448,157	22,622,538
A12q13.11-q13.12	46,766,301	51,194,543	D10q23.31	90,567,045	90,986,391
A12q14.2-q21.1	64,762,188	73,252,451	D13q14.13-q14.3	46,917,541	53,172,272
A13q31.3	91,878,316	92,275,215	D15q15.1-q21.1	40,295,857	46,224,648
A16q24.3	89,644,837	89,662,874	D16q12.1-q12.2	50,674,936	52,984,751
A18p11.21-18q23	15,381,304	77,861,995	D17p13.3-p11.2	1,000,000	16,936,602
A19p13.3	260,999	2,183,174	D19p13.3	6,427,364	6,851,788
A19q13.33-q13.43	50,132,339	58,866,674
A21q22.3	43,014,315	47,970,581